us ipo - Search News

Infinity Natural Resources launches IPO

Infinity Natural valued at $1.3 billion in debut as US energy IPOs rebound

Infinity Natural Resources notched a valuation of $1.30 billion after shares of the oil and natural gas producer jumped nearly 11% in their New York Stock Exchange debut on Friday. The listing comes amid a steady stream of initial public offerings by energy companies against the backdrop of a more fossil fuel-friendly Trump administration.

MarketWatch on MSN · 8h

Oil company Infinity Natural Resources debuts IPO amid deregulation push

Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong stock-market debut for the oil and gas producer, which operates in Ohio and Pennsylvania.

Investing.com on MSN · 5h

Infinity Natural Resources launches IPO, starts trading 11% higher

Infinity Natural Resources, an independent energy company, has launched its initial public offering (IPO) today. The company priced 13,250,000 shares of its Class A common stock at $20.00 each. Trading commenced on the New York Stock Exchange (NYSE) under the ticker symbol "INR",

Reuters · 1d

Pearl Energy-backed Infinity Natural Resources raises $265 mln in US IPO

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial public offering in the United States.

Unilever considering IPO of ice cream business in the US

Seeking Alpha on MSN · 6h

Unilever considering IPO of ice cream business in the US - Bloomberg

Unilever Plc (NYSE:UL) is evaluating an initial public offering of its ice cream business in the U.S. The company is also considering a listing of the ice cream unit, which houses brands including Ben & Jerry's and Breyers,

Reuters · 5h

Unilever eyes New York listing for ice-cream business, Bloomberg News reports

Unilever Plc is evaluating options, including a New York listing, for its ice-cream business, Bloomberg News reported on Friday, citing people familiar with the matter.

Bloomberg L.P. · 6h

Unilever Weighs US as Potential Listing Venue for Ice Cream Unit

Unilever Plc is considering New York as a potential venue for a listing of its ice cream business, people with knowledge of the matter said, a move that might trigger a backlash in the unit’s home market of the Netherlands.

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

3don MSN

US Pork Giant Smithfield Foods Raises $522M After Pricing IPO Below Range

Smithfield Foods and its Chinese parent raised around $522 million from the U.S. pork giant's initial public offering after ...

Cement Producer Titan America Seeks up to $3.3 Billion Valuation in US IPO

(Reuters) - Titan America is seeking a valuation of up to $3.32 billion in its New York initial public offering, the ...

Drug developer Maze Therapeutics eyes up to $728 million valuation in US IPO

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

Northpointe Bancshares Begins $201 Million IPO Effort

Northpointe Bancshares plans $201.25M IPO for retail banking, residential lending, and digital deposit banking. Explore more ...

4don MSN

J&J-Backed Medtech Firm HistoSonics Considers US IPO

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

3don MSN

Smithfield Foods to Keep US Pork Plants Open, Eyes Tariffs Amid IPO, CEO Says

(Reuters) - Smithfield Foods does not plan to close more U.S. pork processing plants, Chief Executive Shane Smith said on ...

Karman Holdings Aims High With $100 Million US IPO Plan

Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...

Upstream2d

What Venture Global’s IPO means for its founders' net worth — and for the company

Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...

Ascentage Pharma’s US Shares Climb After $126 Million IPO

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Biocon Biologics plans IPO for biosimilars business by Mar 2026: CEO

The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results